Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Enzalutamide
Related studies linked through entity extraction aliases.
A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden
- Status
- COMPLETED
- Phase
- N/A
A Study of Patient Preference Between ODM-201 and Enzalutamide in Men With Metastatic Castrate-resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations
- Status
- COMPLETED
- Phase
- PHASE1
ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Dynamics of Androgen Receptor Genomics and Transcriptomics After Neoadjuvant Androgen Ablation
- Status
- COMPLETED
- Phase
- PHASE2
Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Enzalutamide and External Beam Hypofractionated Radiotherapy For Intermediate Risk Localized Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Effect of Enzalutamide Dose Reduction on Fatigue, Cognition, and Drug Trough Levels in Patients With Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen
- Status
- COMPLETED
- Phase
- PHASE3
Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)
- Status
- COMPLETED
- Phase
- PHASE3
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Efficacy and Safety Study of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE4